Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intravenous Immunoglobulin Therapy in Pediatric Narcolepsy: A Nonrandomized, Open-Label, Controlled, Longitudinal Observational Study
Michel Lecendreux, Johanna Berthier, Jennifer Corny, et al.
Journal of Clinical Sleep Medicine (2017) Vol. 13, Iss. 03, pp. 441-453
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

European guideline and expert statements on the management of narcolepsy in adults and children
Claudio L. Bassetti, Ulf Kallweit, Luca Vignatelli, et al.
European Journal of Neurology (2021) Vol. 28, Iss. 9, pp. 2815-2830
Open Access | Times Cited: 115
The clinical spectrum of childhood narcolepsy
Emanuela Postiglione, Elena Antelmi, Fabio Pizza, et al.
Sleep Medicine Reviews (2017) Vol. 38, pp. 70-85
Closed Access | Times Cited: 100
Recent advances in treatment for narcolepsy
Lucie Barateau, Yves Dauvilliers
Therapeutic Advances in Neurological Disorders (2019) Vol. 12
Open Access | Times Cited: 84
European guideline and expert statements on the management of narcolepsy in adults and children
Claudio L. Bassetti, Ulf Kallweit, Luca Vignatelli, et al.
Journal of Sleep Research (2021) Vol. 30, Iss. 6
Open Access | Times Cited: 76
Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment
Kiran Maski, Lynn Marie Trotti, Suresh Kotagal, et al.
Journal of Clinical Sleep Medicine (2021) Vol. 17, Iss. 9, pp. 1895-1945
Open Access | Times Cited: 63
Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy
Marinos C. Dalakas
Neurotherapeutics (2021) Vol. 18, Iss. 4, pp. 2397-2418
Open Access | Times Cited: 62
Narcolepsy Associated with Pandemrix Vaccine
Tomi Sarkanen, Anniina Alakuijala, Ilkka Julkunen, et al.
Current Neurology and Neuroscience Reports (2018) Vol. 18, Iss. 7
Open Access | Times Cited: 68
Central hypersomnia and chronic insomnia: expanding the spectrum of sleep disorders in long COVID syndrome - a prospective cohort study
Alissa Elen Formiga Moura, Danilo Nunes Oliveira, Danielle Mesquista Torres, et al.
BMC Neurology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 28
From past to future: 50 years of pharmacological interventions to treat narcolepsy
Éric Konofal
Pharmacology Biochemistry and Behavior (2024) Vol. 241, pp. 173804-173804
Open Access | Times Cited: 6
Cataplexy and Its Mimics: Clinical Recognition and Management
Sigrid Pillen, Fabio Pizza, Karlien Dhondt, et al.
Current Treatment Options in Neurology (2017) Vol. 19, Iss. 6
Closed Access | Times Cited: 54
Narcolepsy treatment: pharmacological and behavioral strategies in adults and children
Christian Franceschini, Fabio Pizza, Elena Antelmi, et al.
Sleep And Breathing (2019) Vol. 24, Iss. 2, pp. 615-627
Open Access | Times Cited: 39
A practical guide to the pharmacological and behavioral therapy of Narcolepsy
Christian Franceschini, Fabio Pizza, Francesca Cavalli, et al.
Neurotherapeutics (2021) Vol. 18, Iss. 1, pp. 6-19
Open Access | Times Cited: 29
Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment
Lucie Barateau, Roland Liblau, Christelle Peyron, et al.
CNS Drugs (2017) Vol. 31, Iss. 10, pp. 821-834
Closed Access | Times Cited: 36
Pediatric Narcolepsy—A Practical Review
I-Hang Chung, Wei‐Chih Chin, Yu‐Shu Huang, et al.
Children (2022) Vol. 9, Iss. 7, pp. 974-974
Open Access | Times Cited: 16
Narcolepsy type 1: what have we learned from immunology?
Birgitte Rahbek Kornum
SLEEP (2020) Vol. 43, Iss. 10
Open Access | Times Cited: 24
Intravenous immunoglobulin induces IgG internalization by tolerogenic myeloid dendritic cells that secrete IL-10 and expand Fc-specific regulatory T cells
Li‐En Hsieh, Jaeyoon Song, Adriana H. Tremoulet, et al.
Clinical & Experimental Immunology (2022) Vol. 208, Iss. 3, pp. 361-371
Open Access | Times Cited: 14
Connecting the dots: An updated review of the role of autoimmunity in narcolepsy and emerging immunotherapeutic approaches
Parya Valizadeh, Sara Momtazmanesh, Giuseppe Plazzi, et al.
Sleep Medicine (2023) Vol. 113, pp. 378-396
Closed Access | Times Cited: 8
Development of the pediatric narcolepsy patient-reported outcomes scale (PN-PROs)
Grace Wang, Jennifer Worhach, Eric S. Zhou, et al.
Frontiers in Sleep (2024) Vol. 3
Open Access | Times Cited: 2
Reviewing the Clinical Implications of Treating Narcolepsy as an Autoimmune Disorder
Maria Pia Giannoccaro, Rocco Liguori, Giuseppe Plazzi, et al.
Nature and Science of Sleep (2021) Vol. Volume 13, pp. 557-577
Open Access | Times Cited: 14
Approach to a sleepy child: Diagnosis and treatment of excessive daytime sleepiness in children and adolescents
Oliviero Bruni
European Journal of Paediatric Neurology (2022) Vol. 42, pp. 97-109
Closed Access | Times Cited: 10
Narcolepsy Type I as an autoimmune disorder
Birgitte Rahbek Kornum
Handbook of clinical neurology (2021), pp. 161-172
Closed Access | Times Cited: 13
Intravenous Immunoglobulin Therapy Administered Early after Narcolepsy Type 1 Onset in Three Patients Evaluated by Clinical and Polysomnographic Follow-Up
Élisabeth Ruppert, Hélène Zagala, Juliette Chambe, et al.
Behavioural Neurology (2018) Vol. 2018, pp. 1-5
Open Access | Times Cited: 14
Immunotherapy in Narcolepsy
Maria Pia Giannoccaro, Giombattista Sallemi, Rocco Liguori, et al.
Current Treatment Options in Neurology (2020) Vol. 22, Iss. 1
Closed Access | Times Cited: 12
Ofatumumab treatment in new‐onset narcolepsy type 1 following SARS‐CoV‐2 infection
Xiaoli Wang, Xinbo Zhang, Na Yuan, et al.
Annals of Clinical and Translational Neurology (2024)
Open Access | Times Cited: 1
The case for narcolepsy as an autoimmune disease
Birgitte Rahbek Kornum, Poul Jennum
Expert Review of Clinical Immunology (2020) Vol. 16, Iss. 3, pp. 231-233
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top